Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Cartesian Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 95 | 1 | 92 | −2 |
| Shares | 46.8M | 11.3K | 56.5M | +9.71M (+20.8%) |
| Value | $65.1M | $15.7K | $63.2M | −$1.80M (−2.8%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen Asset Management, LLC | 672,740 | $753.5K | 0.00% |
| Tang Capital Management LLC | 400,000 | $448.0K | 0.07% |
| XTX Topco Ltd | 148,242 | $166.0K | 0.03% |
| Rhumbline Advisers | 119,802 | $134.2K | 0.00% |
| New York State Common Retirement Fund | 84,800 | $95.0K | 0.00% |
| UBS Group AG | 63,613 | $71.2K | 0.00% |
| MetLife Investment Management | 62,179 | $69.6K | 0.00% |
| American International Group, Inc. | 55,902 | $62.6K | 0.00% |
| Virtu Financial LLC | 55,759 | $62.0K | 0.00% |
| Voya Investment Management LLC | 49,796 | $55.8K | 0.00% |
| California State Teachers Retirement System | 38,635 | $43.3K | 0.00% |
| HighTower Advisors, LLC | 25,200 | $28.0K | 0.00% |
| Journey Advisory Group, LLC | 25,000 | $28.0K | 0.00% |
| Alliancebernstein L.P. | 22,720 | $25.4K | 0.00% |
| Gladius Capital Management LP | 17,143 | $19.2K | 0.01% |
| Principal Financial Group Inc | 12,690 | $14.2K | 0.00% |
| Amalgamated Bank | 12,930 | $14.0K | 0.00% |
| Legal & General Group Plc | 12,489 | $14.0K | 0.00% |
| State of Wisconsin Investment Board | 11,100 | $12.4K | 0.00% |
| Ameritas Investment Partners, Inc. | 9,591 | $10.7K | 0.00% |
| Metropolitan Life Insurance Co | 6,443 | $7.22K | 0.00% |
Sold out (23)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Acadian Asset Management LLC | 1,509,229 | $2.10M |
| Marshall Wace, LLP | 1,298,751 | $1.81M |
| HSBC Holdings PLC | 600,000 | $834.0K |
| Qube Research & Technologies Ltd | 446,030 | $620.0K |
| HRT Financial LP | 382,971 | $532.0K |
| Gsa Capital Partners LLP | 332,726 | $462.0K |
| BlueCrest Capital Management Ltd | 330,292 | $459.1K |
| Two Sigma Investments, LP | 201,323 | $279.8K |
| EcoR1 Capital, LLC | 200,000 | $278.0K |
| Man Group plc | – | $269.9K |
| Jump Financial, LLC | 91,600 | $127.3K |
| LMR Partners LLP | 67,088 | $93.3K |
| Balyasny Asset Management LLC | 48,936 | $68.0K |
| Caxton Associates LP | 24,407 | $33.9K |
| ExodusPoint Capital Management, LP | 24,000 | $33.0K |
| Jefferies Financial Group Inc. | 20,830 | $29.0K |
| Cubist Systematic Strategies, LLC | 18,276 | $25.4K |
| Engineers Gate Manager LP | 18,222 | $25.3K |
| Point72 Middle East FZE | 11,867 | $16.5K |
| Belpointe Asset Management LLC | 9,631 | $13.4K |
| Psagot Value Holdings Ltd. / (Israel) | 1,981 | $3.00K |
| CWM, LLC | 6 | $0 |
| Mirabella Financial Services LLP | 145,423 | – |
Not filed for Q2 2023 yet (1)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| CTC Capital Management, LLC | 11,300 | $15.7K |